Correction: Pyrotinib promotes the antitumor effect of T-DM1 by increasing drug endocytosis in HER2-positive breast cancer

Wenjun Ren^#¹, Jiankun Liu², Ruijing Zhao³, Fei Zhao¹, Yimei Zhang⁴, Jianping Mu⁵, Tienian Zhu^#^{6

7}

Affiliations

¹ Department of Oncology, Hebei Medical University, Shijiazhuang, 050017, Hebei, China.
² Department of Medical Oncology, Bethune International Peace Hospital, Shijiazhuang, 050082, Hebei, China. liujiankun1982@163.com.
³ Department of Immunology, Key Laboratory of Immune Mechanism and Intervention on Serious Disease in Hebei Province, Hebei Medical University, Shijiazhuang, 050017, Hebei, China.
⁴ Department of Medical Oncology, Bethune International Peace Hospital, Shijiazhuang, 050082, Hebei, China.
⁵ Department of Oncology, ShengJi Cancer Hospital, Handan, 056000, Hebei, China.
⁶ Department of Oncology, Hebei Medical University, Shijiazhuang, 050017, Hebei, China. zhutienian2023@outlook.com.
⁷ Department of Medical Oncology, Bethune International Peace Hospital, Shijiazhuang, 050082, Hebei, China. zhutienian2023@outlook.com.

^# Contributed equally.

Published Erratum

Wenjun Ren et al. Sci Rep. 2026.

. 2026 Jan 23;16(1):3062.

doi: 10.1038/s41598-026-36768-9.

Wenjun Ren^#¹, Jiankun Liu², Ruijing Zhao³, Fei Zhao¹, Yimei Zhang⁴, Jianping Mu⁵, Tienian Zhu^#^{6

7}

¹ Department of Oncology, Hebei Medical University, Shijiazhuang, 050017, Hebei, China.
² Department of Medical Oncology, Bethune International Peace Hospital, Shijiazhuang, 050082, Hebei, China. liujiankun1982@163.com.
³ Department of Immunology, Key Laboratory of Immune Mechanism and Intervention on Serious Disease in Hebei Province, Hebei Medical University, Shijiazhuang, 050017, Hebei, China.
⁴ Department of Medical Oncology, Bethune International Peace Hospital, Shijiazhuang, 050082, Hebei, China.
⁵ Department of Oncology, ShengJi Cancer Hospital, Handan, 056000, Hebei, China.
⁶ Department of Oncology, Hebei Medical University, Shijiazhuang, 050017, Hebei, China. zhutienian2023@outlook.com.
⁷ Department of Medical Oncology, Bethune International Peace Hospital, Shijiazhuang, 050082, Hebei, China. zhutienian2023@outlook.com.

^# Contributed equally.

No abstract available

Erratum for

Pyrotinib promotes the antitumor effect of T-DM1 by increasing drug endocytosis in HER2-positive breast cancer.
Ren W, Liu J, Zhao R, Zhao F, Zhang Y, Mu J, Zhu T. Ren W, et al. Sci Rep. 2025 May 28;15(1):18625. doi: 10.1038/s41598-025-03678-1. Sci Rep. 2025. PMID: 40437017 Free PMC article.